Guardant Health (GH) Receivables - Net (2017 - 2026)

Guardant Health has disclosed Receivables - Net across 10 years of filings, most recently posting $137.4 million for Q1 2026.

• Receivables - Net for Q1 2026 came in at $137.4 million, up 19.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $137.4 million (up 19.04% YoY), and the FY2025 annual result was $137.8 million, up 25.03% from the prior year.
• Receivables - Net came in at $137.4 million for Q1 2026 at Guardant Health, roughly flat from $137.8 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $137.8 million in Q4 2025 to a low of $84.3 million in Q1 2022.
• The 5-year median for Receivables - Net is $95.3 million (2022), against an average of $102.0 million.
• Across the five-year window, Receivables - Net jumped 77.53% in 2022 and decreased 9.24% in 2023, its largest moves.
• Guardant Health's Receivables - Net stood at $97.3 million in 2022, then slipped by 8.71% to $88.8 million in 2023, then rose by 24.18% to $110.3 million in 2024, then advanced by 25.03% to $137.8 million in 2025, then declined by 0.32% to $137.4 million in 2026.
• The last three Receivables - Net figures came in at $137.4 million (Q1 2026), $137.8 million (Q4 2025), and $115.6 million (Q3 2025), per Business Quant data.